| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHINTE.1976.03630090033009 |
| P698 | PubMed publication ID | 962443 |
| P50 | author | Alfred D Steinberg | Q117315555 |
| P2093 | author name string | Budman DR | |
| P433 | issue | 9 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| kidney disease | Q1054718 | ||
| hypertension | Q95566669 | ||
| P304 | page(s) | 1003-1007 | |
| P577 | publication date | 1976-09-01 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | Hypertension and renal disease in systemic lupus erythematosus | |
| P478 | volume | 136 |
| Q34102164 | A Case of Systemic Lupus Erythematosus Presenting as Malignant Hypertension with Hypertensive Retinopathy |
| Q28085576 | An impaired neuroimmune pathway promotes the development of hypertension in systemic lupus erythematosus |
| Q38841726 | Anti-CD3 antibody therapy attenuates the progression of hypertension in female mice with systemic lupus erythematosus |
| Q39378416 | Autoimmune therapeutic chloroquine lowers blood pressure and improves endothelial function in spontaneously hypertensive rats |
| Q35116086 | Autoimmunity: an underlying factor in the pathogenesis of hypertension |
| Q35543439 | Blood pressure in a hypertensive mouse model of SLE is not salt-sensitive |
| Q33961468 | Can estrogens promote hypertension during systemic lupus erythematosus? |
| Q33567470 | Cholinergic agonists reduce blood pressure in a mouse model of systemic lupus erythematosus |
| Q77798502 | Current role of renal biopsy in patients with SLE |
| Q64280996 | Cyclophosphamide treatment for hypertension and renal injury in an experimental model of systemic lupus erythematosus |
| Q35162962 | Estrogen in cardiovascular disease during systemic lupus erythematosus |
| Q41922310 | Evolution of chronic kidney disease in patients with systemic lupus erythematosus over a long-period follow-up: a single-center inception cohort study |
| Q37174707 | Female spontaneously hypertensive rats have greater renal anti-inflammatory T lymphocyte infiltration than males |
| Q38938727 | Immunosuppression With Mycophenolate Mofetil Attenuates Hypertension in an Experimental Model of Autoimmune Disease |
| Q64283956 | Mechanisms of hypertension in autoimmune rheumatic diseases |
| Q41668485 | Mortality in lupus nephritis |
| Q39819349 | Natural history of hypertension in renal parenchymal disease |
| Q36932669 | Oxidative stress promotes hypertension and albuminuria during the autoimmune disease systemic lupus erythematosus |
| Q50616527 | Persistent hypertension in lupus nephritis and the associated risk factors |
| Q47548339 | Plasma Cell Depletion Attenuates Hypertension in an Experimental Model of Autoimmune Disease |
| Q77798512 | Prevention and treatment of adverse effects of corticosteroids in systemic lupus erythematosus |
| Q40506590 | Prognosis in systemic lupus erythematosus |
| Q40506580 | Systemic lupus erythematosus--disease management |
| Q33562068 | Systemic lupus erythematosus. III. Observations on clinical renal involvement and follow up of renal function: Dutch experience with 110 patients studied prospectively. |
| Q90159347 | Temporal Hemodynamic Changes in a Female Mouse Model of Systemic Lupus Erythematosus |
| Q33535433 | The heart in systemic lupus erythematosus |
| Q37233020 | The pathophysiology of hypertension in systemic lupus erythematosus |
| Q36727769 | The significance of arterial hypertension at the onset of clinical lupus nephritis |
| Q39749422 | The treatment of lupus nephritis |
| Q35857868 | Transfer of renovascular hypertension and coronary heart disease by lymphoid cells from SLE-prone mice |
| Q34339359 | Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus |
| Q38777852 | Understanding mechanisms of hypertension in systemic lupus erythematosus |
| Q70843046 | [Malignant hypertension and systemic lupus erythematosus: apropos of a case with a favorable outcome] |
Search more.